Japan· JP-3999073F3023
レニオリシブリン酸塩
A leniolisib product containing レニオリシブリン酸塩, registered in Japan by オーファンパシフィック, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Leniolisib is registered in 11 of 19 countries.
Countries holding a registration under ATC L03AX22 (leniolisib), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Leniolisib · ATC L03AX22
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- レニオリシブリン酸塩
- Manufacturer
- オーファンパシフィック
- Country
- Japan (JP)
- ATC code
- L03AX22
- ATC class
- Leniolisib
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L03AX22
Leniolisib, as other registers publish it.
- United StatesJoenjaPharming Healthcare Inc.
- FinlandJoenjaPharming Technologies B.V.
- IcelandJoenjaPharming Technologies B.V.
- United StatesJoenjaPharming Healthcare Inc.
- DenmarkJoenjaPharming Group N.V.
- PolandJoenjaPharming Technologies B.V.
- CzechiaJOENJAPharming Technologies B.V., Leiden
- BelgiumJoenja 70 mgPharming Technologies
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e56eac04-1388-4dcf-9e8d-cf135b1a4886 GET /v1/drugs/e56eac04-1388-4dcf-9e8d-cf135b1a4886?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "７０ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999073F3023",
"category": "内用薬",
"price_yen": 9287,
"generic_name": "レニオリシブリン酸塩",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": "9287"
}See everything about leniolisib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.